Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2016

GlobalData
219 Pages - GLDATA49831
$2,500.00

Summary

GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2016" provides an overview of Ankylosing Spondylitis (Bekhterev's Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Ankylosing Spondylitis (Bekhterev's Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

Pfizer Inc.
AbbVie Inc.
Johnson & Johnson
Merck & Co., Inc.
C. H. Boehringer Sohn AG & Co. KG
Novartis AG
UCB S.A.
Parexel International Corporation
Celgene Corporation
Amgen Inc.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Ankylosing Spondylitis (Bekhterev's Disease) 33
Mar 18, 2016: Celltrion Healthcare: Switching to Remsima (infliximab) from originator has no negative effect on safety or efficacy in 10 real-world studies 33
Mar 16, 2016: Significantly higher persistence with SIMPONI (golimumab) in patients with rheumatic diseases compared with other subcutaneous TNF-alpha inhibitors, new study reveals 34
Clinical Trial Profile Snapshots 35
Appendix 216
Abbreviations 216
Definitions 216
Research Methodology 217
Secondary Research 217
About GlobalData 218
Contact Us 218
Disclaimer 218
Source 219

List of Tables
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14
Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2016* 16
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2016* 20
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Phase, 2016* 23
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 24
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 28
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32

List of Figures
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14
Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2016* 15
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2016* 19
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 23
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 24
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 28
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32
GlobalData Methodology 217

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports